Scope of the Study
Intravenous (IV) cannula is a very small, flexible tube which is placed into one of the veins, usually in the back of the hand or in the arm used intravenous administration of medication or infusions. It is generally made of polyurethane thermoplastic material which is highly biocompatible, enabling the cannula to remain in place for a prolonged period. There are various types of cannula sizes used in hospitals. Its size varies according to its types and uses.
The market study is being classified, by Application (Medicine Administration, Intravenous Fluid Administration and Others) and major geographies with country level break-up.
Boston Scientific Corporation (United States), Teleflex Incorporated (United States), CONMED Corporation (United States), Sorin Group (Italy), Edward Lifescience (United States), Medtronic plc (Ireland), Terumo Corporation (Japan), Smith & Nephew plc (United Kingdom), Smiths Medical, Inc. (United States) and MAQUET Holding B.V. & Co. KG (Germany) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Armstrong Medical Ltd (United Kingdom) and Omex Medical Technology (India).
Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Intravenous (IV) Cannula market throughout the predicted period.
AdvanceMarketAnalytics has segmented the market of Global Intravenous (IV) Cannula market by Type, Application and Region.
On the basis of geography, the market of Intravenous (IV) Cannula has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increased Number of Surgeries and Minimally Invasive Procedures
- Growth in the Healthcare Infrastructure in Developing Countries
- Various Applications of Intravenous Cannula
- Increased Demand for Medical Supplies Worldwide
- Increased Prevalence of Cardiac Diseases
- Complications Associated with Intravenous Cannula
- Growth in the Health Care Industry Worldwide
- Increasing Number of COVID-19 Patients Worldwide results in Hospitalization of the Patients
- Increasing Competition in the Market
Market Leaders and their expansionary development strategies
In August 2019, Boston Scientific Corporation has announced the completion of its acquisition of BTG plc. pursuant to the previously announced scheme of arrangement. BTG develops and commercializes products used in minimally-invasive procedures targeting cancer and vascular diseases, as well as specialty pharmaceuticals.
Key Target AudienceIntravenous (IV) Cannula Manufacturers, Raw Material Suppliers, Distributors, Emerging Companies and End-users
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase